Skip to main content
Skip to main content
Go to homepage

Study of Blood Samples From Newborns With Down Syndrome (AAML08B1)

Study of Blood Samples From Newborns With Down Syndrome

Description:

For complete study information, please view the study on clinicaltrials.gov.

Study Status:
Closed
Full IRB Study Title:
AAML08B1: Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
IRB Study ID:
969979-1
If you are interested in this study or have questions about your child's eligibility, please contact:
Rebecca D. Considine Research Institute, 330-543-3193 or email research@akronchildrens.org
Lead Investigator
Steven Kuerbitz, MD

Director, Divisional Research, Stem Cell Transplantation & Shannon E. Wilkes Targeted Therapy Program; The Jeffrey A. Barbour Chair for Pediatric Hematology Oncology Research and Healing; Pediatric Hematologist-Oncologist
Showers Family Center for Childhood Cancer and Blood DisordersPediatric Stem Cell Transplant Program